oncology solutions: experience. insight. results
DESCRIPTION
Did you know that 47 of the 50 best-selling oncology drugs in 2013 were developed in partnership with Covance? Yours could be next. Discover how Covance CLS delivers the solutions you require to successfully achieve your drug development goals.TRANSCRIPT
ONCOLOGY SOLUTIONSEXPERIENCE. INSIGHT. RESULTS.
OUR CAPABILITIES — YOUR TESTING SOLUTIONS
Your Study + Our Project Management Team = RESULTS
141,000+ patients
Genomics and
Biomarkers
Companion Diagnosticssolutions
Dx
Pharma
Covance
CDx
1,000+protocols
SAFETY TESTING
Hematology andFlow Cytometry
GlobalDigitalPathology
AnatomicPathologyServices
47 of the 50 best-selling oncology drugs in 2013 were developed in partnership with us—yours is next
Most preferred central laboratory
OUR PEOPLE — YOUR RELENTLESS RESOURCES
Global SOPs + Same Reagents + Lot Controls = DATA CONSISTENCY
Covance is an independant, publicly held company with headquarters in Princeton, New Jersey, USA.
Covance is the marketing name for Covance Inc. and its subsidiaries around the world. Copyright © 2014.
= DEPENDABILITYProactive Contingency Planning
In the past 5 years alone (2009–2013)
24,000+ investigator sites
75+ countries